Selectivity of Cyclic [d-Nal7] and [d-Phe7] Substituted MSH Analogues for the Melanocortin Receptor Subtypes
- 10 January 1997
- Vol. 18 (7) , 1009-1013
- https://doi.org/10.1016/s0196-9781(97)00079-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical studyLife Sciences, 1996
- Cyclic lactam .alpha.-melanotropin analogs of Ac-Nle4-cyclo[Asp5,D-Phe7,Lys10]-.alpha.-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptorsJournal of Medicinal Chemistry, 1995
- Receptors for the melanocortin peptides in the central nervous systemCurrent Opinion in Endocrinology, Diabetes and Obesity, 1994
- Molecular Cloning of a Novel Human Melanocortin ReceptorBiochemical and Biophysical Research Communications, 1993
- Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNAFEBS Letters, 1992
- The Cloning of a Family of Genes That Encode the Melanocortin ReceptorsScience, 1992
- Potent and prolonged-acting cyclic lactam analogs of .alpha.-melanotropin: design based on molecular dynamicsJournal of Medicinal Chemistry, 1989
- Cyclic melanotropins. 5. Importance of the C-terminal tripeptide (Lys-Pro-Val)Journal of Medicinal Chemistry, 1984
- Structure-activity studies of highly potent cyclic [Cys4, Cys10]melanotropin analogsJournal of Medicinal Chemistry, 1983
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973